Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reducing readmissions for congestive heart failure.

R E Hoyt1, L S Bowling

  • 1Internal Medicine Clinic, Naval Hospital Pensacola, Florida 32512-0003, USA.

American Family Physician
|May 1, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibiotic sensitivity tests on microaerophilic bacteria and on strains of Mycobacterium tuberculosis, using compressed tablets.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Antibiotic sensitivity testing; a survey of commercially available testing sets.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Staphylococcus aureus endocarditis; treatment with penicillin; report of a case.

California and western medicine·2010
Same author

The use of pectin and gelatin in the processing of plasma in the blood bank.

American journal of clinical pathology·2010
Same author

Scleroma; complement fixation test.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·2010
Same author

A survey of commercial Rh antiserums.

American journal of clinical pathology·2010

New medications and therapies can significantly reduce hospital admissions for congestive heart failure. Treatment guidelines recommend specific drugs and exercise to improve patient outcomes and quality of life.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pharmacology

Background:

  • Hospital admissions for congestive heart failure (CHF) are common, costly, and often preventable.
  • New pharmacological and therapeutic interventions aim to reduce CHF-related hospitalizations, morbidity, and mortality.
  • Improving the quality of life for CHF patients is a key objective of current medical practice.

Purpose of the Study:

  • To outline current evidence-based treatment strategies for patients with decreased systolic function and heart failure.
  • To highlight the role of specific medications, including ACE inhibitors, ARBs, beta blockers, and spironolactone, in managing CHF.
  • To emphasize the importance of recommending exercise programs for stable CHF patients.

Main Methods:

  • Review of current medical literature and clinical guidelines for heart failure management.

Related Experiment Videos

  • Focus on pharmacological interventions for patients with ejection fraction < 40% and NYHA class II/III heart failure.
  • Inclusion of non-pharmacological recommendations such as exercise programs.

    • Main Results:

    • Angiotensin-converting enzyme (ACE) inhibitors are first-line therapy for eligible patients; angiotensin II receptor blockers (ARBs) serve as an alternative.
    • Beta blockers (metoprolol, carvedilol, bisoprolol) are recommended for patients with NYHA class II or III heart failure.
    • Spironolactone has demonstrated benefits in improving mortality and reducing hospital readmission rates.
    • Exercise programs are beneficial for stable heart failure patients.

    Conclusions:

    • Evidence-based pharmacotherapy, including ACE inhibitors/ARBs, beta blockers, and spironolactone, is crucial for managing CHF.
    • Tailored medication regimens and lifestyle recommendations, such as exercise, can significantly improve outcomes for CHF patients.
    • Adherence to updated treatment guidelines can reduce hospital admissions and enhance the quality of life for individuals with heart failure.